Why use intravenous antibiotics when oral will do?

Pharmaceutical Journal

Volumn 261, Issue 7016, 1998, Pages 630-632

  Maidment, Ian D ^a,b  

^a NORFOLK AND SUFFOLK NHS FOUNDATION TRUST   (United Kingdom)

^b ROYAL BERKSHIRE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; CEFOTAXIME; CEFTAZIDIME; CEFUROXIME; CIPROFLOXACIN; CLARITHROMYCIN; ERYTHROMYCIN; FLUCLOXACILLIN; GENTAMICIN; MEROPENEM; METRONIDAZOLE; PENICILLIN G; TEICOPLANIN; VANCOMYCIN;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; CLINICAL ARTICLE; COST CONTROL; DRUG COST; DRUG USE; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; ORAL DRUG ADMINISTRATION; PRACTICE GUIDELINE; TREATMENT OUTCOME;

EID: 0032541888     PISSN: 00316873     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Davey P, Dodd T, Kerr S, Malek M. Audit of IV antibiotic administration. Pharm J 1990;244:793-6.
2. Smyth ETM, Barr JG, O'Neill CA, Hogg GM. An assessment of the hidden and total antibiotic costs of four parenteral cephalosporins. Pharmacoeconomics 1995;8:541-50.
3. O'Brien A, Gow GL. Rationalise antibiotic usage. Pharmacy in Practice 1996;34:40.
4. Janknegt R, Van der Meer JWM. Antimicrobial practice. Sequential therapy with intravenous and oral cephalosporins. J Antimicrob Chemother 1994;33:109-77.
5. Chan R, Hemeryck L, O'Regan M, Clancy L, Feely J. Oral versus intravenous antibiotics for community acquired lower respiratory tract infection in a general hospital: open, randomised controlled trial. BMJ 1995;310:1360-2.
6. Allen B, Naismith NW, Manser AJ, Moulds RFW. A campaign to improve the timing of conversion from intravenous to oral administration of antibiotics. Austral J Hosp Pharm 1992;22:433-9.
7. Paladino JA, Sperry HE, Backes JM, Gelber JA, Serrianne DJ, Lumbo TJ et al. Clinical and economic evaluation of oral ciprofloxacin after an abbreviated course of intravenous antibiotics. Am J Med 1991;91:462-70.
8. Malfair SC, Frighetto L, Nickoloff DM, Martinusen SM, Jewesson PJ. Evaluation of the use of cefuroxime and cefuroxime axetil in an intravenous-oral stepdown program. Ann Pharmacother 1996;30:337-42.
9. Hamilton-Miller JMT. Switch therapy: the theory and practice of early change from patenteral to non-parenteral antibiotic administration. Clin Microbiol Inf 1996;2:12-9.
10. Oxford Catalogue. Reading: NHS Supplies Authority, October 1, 1996.
11. Frighetto L, Nickoloff D, Martinusen SM, Mamdaui FS, Jewesson PJ. Intravenous-to-oral stepdown: four years' experience in a large teaching hospital. Ann Pharmacother 1992;26:1447-51.
12. Standards for pharmaceutical services in health authorities, units and trusts in England. Regional Pharmaceutical Officers' Special Interest Group. December, 1991.
13. Tenover FC, McGowan JF, Reasons for the emergence of antibiotic resistance. Am J Med Sci 1996;311:9-16.
14. Antibiotic-associated colitis. Curr Problems in Pharmacovigilance 1994;20:7.
15. Antibiotic-induced diarrhoea. Drug Ther Bull 1995;33:23-4.